FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Olympia Compounding Pharmacy dba Olympia Pharmacy T-105 Recall

T-105, Papaverine 30 mg/mL Phentolamine 1 mg/mL PGE 10 mcg/mL packaged as a) 5 mL Multi…

Olympia Compounding Pharmacy dba Olympia Pharmacy · Orlando, FL

Risk level
Class III
Reported by FDA
Mar 30, 2022
Recall ID
D-0721-2022
Check your lot numberHow we source this data

Summary

Olympia Compounding Pharmacy dba Olympia Pharmacy recalled T-105 starting Mar 8, 2022. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0721-2022 on Mar 30, 2022. Reason: Super Potent. Status: Terminated.

Why it was recalled

Super Potent

Product description

T-105, Papaverine 30 mg/mL Phentolamine 1 mg/mL PGE 10 mcg/mL packaged as a) 5 mL Multi-dose NDC 73198-0005-05; b) 10 mL Multi-dose NDC 73198-0005-10; Each ML contains: 0.5% Chlorobutanol NF, 0.0005% Edetate Disodium Dihydrate USP, 1.84% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 0.5% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835.

Lot numbers, UPCs & expiration codes

Lots: a) E41F10 Exp. 5/10/22; b) E41G10 Exp. 5/10/22

Where it was sold

Nationwide in the USA including Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0721-2022
Classification
Class III
Status
Terminated
Recall initiated
Mar 8, 2022
FDA report date
Mar 30, 2022
Quantity
1093 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Olympia Compounding Pharmacy dba Olympia Pharmacy

Original FDA data

Every field from FDA enforcement report D-0721-2022, exactly as published.

Show all FDA fields
City
Orlando
State
FL
Status
Terminated
Country
United States
Event ID
89717
Address
6700 Conroy Rd Ste 155
Code information
Lots: a) E41F10 Exp. 5/10/22; b) E41G10 Exp. 5/10/22
Postal code
32835-3515
Report date
Mar 30, 2022
Product type
Drugs
Recall number
D-0721-2022
Classification
Class III
Recalling firm
Olympia Compounding Pharmacy dba Olympia Pharmacy
Product quantity
1093 vials
Termination date
Oct 4, 2023
Reason for recall
Super Potent
Voluntary / mandated
Voluntary: Firm initiated
Product description
T-105, Papaverine 30 mg/mL Phentolamine 1 mg/mL PGE 10 mcg/mL packaged as a) 5 mL Multi-dose NDC 73198-0005-05; b) 10 mL Multi-dose NDC 73198-0005-10; Each ML contains: 0.5% Chlorobutanol NF, 0.0005% Edetate Disodium Dihydrate USP, 1.84% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 0.5% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835.
Distribution pattern
Nationwide in the USA including Puerto Rico.
Recall initiation date
Mar 8, 2022
Initial firm notification
Letter
Center classification date
Mar 29, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0721-2022, published Mar 30, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls